MedPath

Ambrisentan

These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for . AMBRISENTAN tablets, for oral use Initial U.S. Approval: 2007

Approved
Approval ID

32549c43-f8ff-422c-b42d-ca0877e661cf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 30, 2019

Manufacturers
FDA

Actavis Pharma, Inc.

DUNS: 119723554

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ambrisentan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0591-2406
Application NumberANDA208252
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ambrisentan
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 30, 2019
FDA Product Classification

INGREDIENTS (10)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5P
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
AMBRISENTANActive
Quantity: 10 mg in 1 1
Code: HW6NV07QEC
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
LECITHIN, SOYBEANInactive
Code: 1DI56QDM62
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

Ambrisentan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0591-2405
Application NumberANDA208252
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ambrisentan
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 30, 2019
FDA Product Classification

INGREDIENTS (10)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
AMBRISENTANActive
Quantity: 5 mg in 1 1
Code: HW6NV07QEC
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LECITHIN, SOYBEANInactive
Code: 1DI56QDM62
Classification: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5P
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

Drug Labeling Information

BOXED WARNING SECTION

LOINC: 34066-1Updated: 9/30/2019

WARNING: EMBRYO-FETAL TOXICITY

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ambrisentan - FDA Drug Approval Details